Huabo Neutron Technology

Huabo Neutron Technology

Accelerator-based boron neutron capture therapy systems for oncology.

HQ location
Hangzhou, China
Website
Launch date
Enterprise value
$110—165m
Notes (0)
More about Huabo Neutron Technology
Made with AI
Edit

Huabo Neutron Technology (Hangzhou) Co., Ltd. specializes in the design, development, and manufacturing of accelerator-driven Boron Neutron Capture Therapy (BNCT) systems for cancer treatment. BNCT is a targeted radiotherapy that involves two steps: a patient is first injected with a boron-10 enriched drug that accumulates in tumor cells, and then the tumor area is irradiated with a neutron beam. The reaction of the neutrons with the boron-10 atoms creates high-energy particles that destroy cancer cells with minimal damage to the surrounding healthy tissue.

The company was founded in March 2023 in Hangzhou and is led by the renowned neutron scientist Professor Sheng Wang. Professor Wang, a foreign academician of the Russian Academy of Natural Sciences, has an extensive background in neutron science and previously led the development of multiple advanced accelerator neutron sources in Japan. In 2015, he established the Advanced Neutron Technology Lab (ANT Lab) at Xi'an Jiaotong University, focusing on the latest generation of BNCT systems. The founding team comprises professors and industry professionals with deep expertise in neutron science, medical equipment, and nuclear medicine.

Huabo Neutron Technology aims to provide a complete solution, including the necessary devices, drugs, and software, with all core intellectual property and equipment being domestically produced. The company has already completed the engineering of the world's first accelerator-based BNCT device for animal use and is in the assembly phase for its clinical-use high-current accelerator BNCT system. The business model focuses on making this advanced radiotherapy more accessible and cost-effective compared to traditional methods. Huabo Neutron Technology has secured significant funding, including an angel round of over 100 million RMB and a Pre-A round of several hundred million RMB, to accelerate clinical trials, develop new boron-containing drugs, and promote the commercialization of its BNCT equipment.

Keywords: Boron Neutron Capture Therapy, BNCT, accelerator-based radiotherapy, oncology treatment, medical devices, nuclear medicine, targeted cancer therapy, radiation therapy, neutron accelerators, boron-10, Sheng Wang, advanced radiotherapy, Hangzhou, medical equipment, cancer research, clinical trials, medical technology, hadrontherapy, neutron source, particle therapy

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads